This site is intended for:
katerzia logo mixed - landscape
katerzia logo mixed - landscape
A father wearing a black beanie plays outside with his son who is a pediatric hypertension patient
Actor Portrayal

Proven High Blood Pressure Therapy
 in a Prescription Liquid Formulation

Katerzia (amlodipine) is approved for kids and teens aged 6 years and older with hypertension.

Katerzia droplet bullet icon
Tested in kids and teens: A clinical study of 268 children and teens aged 6 to 17 years with hypertension showed amlodipine to be safe and effective
Katerzia droplet bullet icon
Lowers blood pressure: In the same clinical study, significant reductions in systolic blood pressure were seen, and adverse events were the same as in adult studies
Katerzia droplet bullet icon
Once-daily dosing: Blood pressure control with a single daily liquid administration
Katerzia droplet bullet icon
BHA free/ethanol free
Important Limitation: Doses in excess of 5 mg daily have not been study in pediatric patients.

BHA=butylated hydroxyanisole; FDA=US Food and Drug Administration.
A bottle of FDA-approved Katerzia liquid amlodipine

KATERZIA is FDA-approved liquid amlodipine for children aged 6 years and older, teens, and adults who have challenges swallowing pills.

Katerzia icon piggy bank

Save on Pharmacy Costs
Without Cards or Coupons

Low co-pay discounts are applied automatically at more than 70,000 participating pharmacies across the United States* for most commercially insured patients.†
Learn More

*Approximate participating pharmacies for eVoucherRx™ and Voucher on Demand™.
†Eligibility restrictions and terms and conditions may apply.

Katerzia icon mail

Stay Up to Date on the Latest 
News About Katerzia

Sign up here to join fellow patients, parents, and providers on our secure mailing list for news and updates relating to Katerzia and pediatric hypertension.
Sign Up

*Approximate participating pharmacies for eVoucherRx™ and Voucher on Demand™.
†Eligibility restrictions and terms and conditions may apply.

A young patient with hypertension symptoms smiles and plays on a swing.
Actor Portrayal

Adherence Assists With Efficacy

According to the Pediatric Formulations Task Force of the American Association of Pharmaceutical Scientists (AAPS) children learn to swallow pills at different ages and difficulty swallowing is one reason why children and teens may not take their medicine as prescribed. Even adults can have trouble swallowing pills and tablets.

A systematic review of 10 studies published by the American Academy of Pediatrics showed that patients who take medicine as prescribed have better outcomes and lower costs of care. Among patients with hypertension, effective therapy has been shown to reduce the risk of fatal and nonfatal cardiovascular events.

Pleasant-tasting medication and liquid formulations can potentially help children and teens take their medication successfully.

The AAP Recommends
Amlodipine Oral Suspension
for the management of chronic hypertension in children aged 6 to 17 years.

AAP=American Academy of Pediatrics.
Girl in purple shirt and overalls flexes her bicep with a blood pressure monitor on her arm
Actor Portrayal
Katerzia icon video

Why Compliance Matters in Pediatric Hypertension

Bonnie Smeryage, a nurse practitioner specializing in pediatric hypertension, discusses the importance of patient adherence in managing high blood pressure in children.
Watch Now
Katerzia icon stethoscope

Download the Katerzia Patient and Caregiver Brochure

This PDF contains a summary of key points about Katerzia for your files and provides a handy reference when discussing Katerzia with your healthcare provider.
Download
A father walks around with his smiling young daughter on his shoulders and the rest of his family in tow.
Actor Portrayal

Eliminate the Variability of Compounding, Crushing, and Sprinkling

When you receive an FDA-approved drug like Katerzia from your local pharmacist, you have the assurance of knowing that it has been manufactured in an FDA-validated facility according to current Good Manufacturing Practices (cGMP).

This means you can trust that the consistency and quality of Katerzia is the same from fill to fill, and its liquid formulation allows you to measure exact doses needed.

Katerzia is available in more than 70,000 pharmacies,* so you don’t have to find and drive to a specialty compounding service. And you can count on uniform flavor and consistency from pharmacy to pharmacy and fill to fill.

Finally, prescription drugs like Katerzia generally have broader coverage with fewer restrictions compared with specialty compounded formulas.

*Approximate participating pharmacies for eVoucherRx™ and Voucher on Demand™.
Katerzia icon video

The Benefits of Liquid Formulations for Pediatric Patients

As part of a busy pediatric nephrology practice, Bonnie Smeryage, NP, discusses why she recommends a liquid high blood pressure medication for her patients.
Watch Now
icon locator

Find a Local Pharmacy That Offers Automatic Katerzia Co-pay Discounts

Just enter your ZIP code in our pharmacy finder to see
all of the pharmacies near you that participate in the Katerzia automatic discount program.
Search Now
A pharmacist talks to a mother and her young daughter about filling a Katerzia prescription
Actor Portrayal
azurity solutions patient support logo

Low co-pay discounts available for most commercial insurance plans.*

Your access to Katerzia shouldn’t be limited by your ability to pay. The Azurity Solutions Patient Assistance Program helps eligible patients get the financial support they need.

*Eligibility restrictions and terms and conditions may apply.

Learn More
divider droplet icon

Katerzia Dosing Information

Ready to use. Simply shake before using.

Your doctor will tell you how much Katerzia you or the patient should take. Do not change the dose of Katerzia unless your doctor tells you to do so.

The effective antihypertensive oral dose to lower blood pressure in pediatric patients aged 6 to 17 years is 2.5 mg to 5 mg orally once daily.

Doses of more than 5 mg daily have not been studied in pediatric patients.

IMPORTANT: Ask your pharmacist for an accurate measuring device for use in administering Katerzia.

Katerzia droplet bullet icon
Take Katerzia once a day, with or without food
Katerzia droplet bullet icon
It may be easier if you take Katerzia at the same time every day, such as with breakfast, dinner, or at bedtime
Katerzia droplet bullet icon
Do not take more than 1 dose of Katerzia at a time
Katerzia droplet bullet icon
Always shake Katerzia before use and carefully measure the prescribed dose before you or the patient takes it
Katerzia droplet bullet icon
Make sure you or the patient swallows the entire dose of Katerzia
Katerzia droplet bullet icon
If you have questions about Katerzia, ask your doctor or your pharmacist
icon droplets

If you or the patient take too much Katerzia
Call your doctor or Poison Control (1-800-222-1222) or go to the nearest hospital emergency room right away.

icon katerzia

Missed a dose of Katerzia?
If you or the patient miss a dose of Katerzia, take it as soon as you remember if you are less than 12 hours late. If it has been more than 12 hours, wait and take the next dose as scheduled.

divider droplet icon

Did you know that Azurity Pharmaceuticals offers many FDA-approved liquid formulations? Visit Azurity.com to learn more.

Go Now

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

  • KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

  • Hypertension in adults and children 6 years of age and older to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Coronary Artery Disease:
    • Chronic stable angina.
    • Vasospastic angina (Prinzmetal’s or Variant Angina).
    • Angiographically documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%.

A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in selecting a measuring device. Shake well before using.

ADDITIONAL IMPORTANT SAFETY INFORMATION

Do not use KATERZIA if you are allergic to amlodipine.

What is the most important information I should know about KATERZIA?
KATERZIA may cause serious side effects, including:

  • Low blood pressure: Symptoms of low blood pressure (hypotension) are possible, particularly in patients with serious heart valve disease (severe aortic stenosis). However, acute low blood pressure is unlikely.

  • Increased chest pain or heart attack: Worsening chest pain called angina, and heart attack (acute myocardial infarction) can develop after starting or increasing the dose of Katerzia, particularly in patients with severe obstructive coronary artery disease.

  • Patients with severe liver disease: Patients with severe liver disease may need to start with a lower initial dose of Katerzia.

Before taking KATERZIA, tell your healthcare provider about all your medical conditions, including if you:

  • ever had heart disease
  • ever had liver problems
  • are pregnant or plan to become pregnant. Your doctor will decide if KATERZIA is the best treatment for you.
  • are breastfeeding. Do not breastfeed while taking KATERZIA. You can stop breastfeeding or take a different medicine.


Tell your healthcare provider about all your medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Tell your doctor if you are taking simvastatin, cyclosporine, or tacrolimus. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

The most common side effect of KATERZIA is swelling (edema), which occurs in a dose-related manner. Other adverse experiences not dose-related but reported with an incidence >1.0 % are tiredness, nausea, abdominal pain, and sleepiness.

Store KATERZIA at refrigerated temperature (2°C to 8°C/36°F to 46°F). Avoid freezing and excessive heat. Protect from light.

The Important Safety Information does not include all the information needed to use KATERZIA safely and effectively. Please talk to your healthcare provider and see the complete Prescribing Information for KATERZIA.
To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.
Product labeling, packaging, and imagery are for representation purposes only.

Healthcare provider and patient images on this website are not actual healthcare providers and patients.

The Information contained herein, including product information, is intended only for residents of the United States.

© 2024 Azurity Pharmaceuticals, Inc. All Rights Reserved. All Trademarks referred to are the property of their respective owners.
PP-KAT-US-0059

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

See More

IMPORTANT SAFETY INFORMATION

KATERZIA® (amlodipine) Oral Suspension, 1 mg/mL

INDICATIONS

  • KATERZIA is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of:

  • Hypertension in adults and children 6 years of age and older to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Coronary Artery Disease:
    • Chronic stable angina.
    • Vasospastic angina (Prinzmetal’s or Variant Angina).
    • Angiographically documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%.

A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in selecting a measuring device. Shake well before using.

ADDITIONAL IMPORTANT SAFETY INFORMATION

Do not use KATERZIA if you are allergic to amlodipine.

What is the most important information I should know about KATERZIA?
KATERZIA may cause serious side effects, including:

  • Low blood pressure: Symptoms of low blood pressure (hypotension) are possible, particularly in patients with serious heart valve disease (severe aortic stenosis). However, acute low blood pressure is unlikely.

  • Increased chest pain or heart attack: Worsening chest pain called angina, and heart attack (acute myocardial infarction) can develop after starting or increasing the dose of Katerzia, particularly in patients with severe obstructive coronary artery disease.

  • Patients with severe liver disease: Patients with severe liver disease may need to start with a lower initial dose of Katerzia.

Before taking KATERZIA, tell your healthcare provider about all your medical conditions, including if you:

  • ever had heart disease
  • ever had liver problems
  • are pregnant or plan to become pregnant. Your doctor will decide if KATERZIA is the best treatment for you.
  • are breastfeeding. Do not breastfeed while taking KATERZIA. You can stop breastfeeding or take a different medicine.


Tell your healthcare provider about all your medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Tell your doctor if you are taking simvastatin, cyclosporine, or tacrolimus. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

The most common side effect of KATERZIA is swelling (edema), which occurs in a dose-related manner. Other adverse experiences not dose-related but reported with an incidence >1.0 % are tiredness, nausea, abdominal pain, and sleepiness.

Store KATERZIA at refrigerated temperature (2°C to 8°C/36°F to 46°F). Avoid freezing and excessive heat. Protect from light.

The Important Safety Information does not include all the information needed to use KATERZIA safely and effectively. Please talk to your healthcare provider and see the complete Prescribing Information for KATERZIA.
To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.